.svg)
%20(1).svg)
%20(23).png)
On‑Demand: Webinar - Material Sparing Approaches to Rapid Development and Scale-Up of Complex Drug Products
Missed our webinar? Not problem! You can watch on-demand today.
As drug molecules grow increasingly complex and timelines to First-in-Human (FIH) studies continue to compress, development teams face a critical challenge: how to generate meaningful CMC data while minimizing material use.
This on-demand webinar explores how material-sparing, bench-scale development approaches can do far more than enable early formulation screening. When thoughtfully integrated, scaled-down techniques can deliver representative test materials, inform manufacturing risk, and support confident process scale-up.
What You’ll Learn:
• How material-sparing strategies can accelerate CMC development without compromising data quality
• The role of bench-scale techniques in generating representative, advanceable test articles
• Approaches to integrating formulation selection, enabled intermediates, and patient-centric drug product design
• Real-world case studies demonstrating how scaled-down models support:
◦ In vitro–in vivo comparisons
◦ Predictive stability studies
◦ Analytical method development
• How data from material-sparing models can be leveraged to enable robust, reproducible scale-up for FIH manufacturing and beyond
Through practical examples, this webinar highlights how a comprehensive, integrated approach to material-sparing development can reduce risk, conserve valuable API, and accelerate the path to clinical supply.
Watch Now:
Speaker:
Cindy Chung, PhD
Principal Engineer, Serán
Cindy leads formulation development of drug product intermediates and finished drug products across small molecules and biologics at Serán. With a background spanning bioengineering, chemical engineering, and cellular microenvironments, she brings a patient-centric perspective to pragmatic pharmaceutical development. Cindy holds a PhD in Bioengineering from the University of Pennsylvania and a BS in Chemical Engineering from MIT.
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
